【24h】

25 years of safe handling of cytotoxics (antineoplastics) in Israel.

机译:在以色列安全处理细胞毒素(抗肿瘤药)已有25年。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Israel is a small country, about the size of Wales, located in the eastern corner of the Mediterranean Sea. The Israel Ministry of Health has responsibility for health matters in Israel. All health matters fall under their jurisdiction. HOSPITAL AND CLINICAL PHARMACY IN ISRAEL: There are about 50 hospitals in Israel with between 300 and 1200 beds including 12 specialist tertiary care centres (6 have facilities to perform bone marrow transplantations). The total number of hospital beds is around 30,000. SAFE HANDLING OF CYTOTOXICS IN ISRAEL: Israel's growing population (rising from half a million in 1948 to about 7 million in 2005) has been matched with an equally rapid rise in the use of cytotoxic drugs. The ministry issued guidelines to standardize and harmonize the level of pharmaceutical oncology services in Israel, and improve the professional level of cytotoxic pharmacy services and acknowledged the need to recognize clinical oncology pharmacy as a speciality. DISCUSSION: Over the last 25 years, safe handling of cytotoxics has moved forward in Israel in a manner comparable to that seen in the best of the developed "western" countries.
机译:简介:以色列是一个小国,与威尔士大小差不多,位于地中海的东角。以色列卫生部负责以色列的卫生事务。所有健康事项均在其管辖范围内。以色列的医院和临床药房:以色列大约有50家医院,床位在300到1200之间,包括12个专科三级护理中心(其中6家设有进行骨髓移植的设施)。医院病床总数约为30,000张。以色列对细胞毒的安全处理:以色列人口的增长(从1948年的100万增加到2005年的700万)与使用细胞毒性药物的发展同样迅速。该部发布了指导方针,以标准化和统一以色列的药物肿瘤学服务水平,并提高细胞毒药物服务的专业水平,并承认有必要承认临床肿瘤学药物学是专科。讨论:在过去的25年中,安全处理细胞毒素的方法在以色列以与最先进的“西方”国家类似的方式向前发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号